This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
Cold Fusion on MSN
Breakthrough: Scientists reverse blindness [CRISPR technology]
CRISPR Gene editing therapy is used for the first time in living humans with amazing results. Trump is guilty of mortgage ...
Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine ...
A one-year-old baby boy has received an incredible honour, for helping researchers get one step closer to finding treatment ...
News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback